Acute hepatic porphyria - classification, diagnosis and treatment
DOI:
https://doi.org/10.12775/JEHS.2023.13.01.019Keywords
porphyria, hepatic porphyrias, heme, metabolic diseasesAbstract
Porphyrias belong to the group of inherited metabolic diseases. Each of the four types of acute hepatic porphyria is caused by a different mutation in the gene of an enzyme involved in the heme biosynthetic pathway. The literature distinguishes between: Acute Intermittent Porphyria (AIP), Hereditary Coproporphyria (HCP), Variegate Porphyria (VP) and Aminolevulinic Dehydratic ADP (ADP) deficiency. -deficient Porphyria). Deficiency of individual enzymes leads to ineffective heme production and accumulation of neurotoxic intermediates - the so-called porphyrins. Two excess metabolites are of major importance in diagnostics - ALA (amionolevulinic acid) and PBG (porphobilinogen). In most cases, the activity of the less functional enzyme is so high that the disease never becomes apparent (latent form). Excessive accumulation of porphyrin precursors is associated with exposure to porphyrinogenic factors, leading to a seizure whose symptoms are closely related to autonomic, peripheral neuropathy, and accompanying neuropsychiatric disorders. In diagnostics, particular attention should be paid to the circumstances of the symptoms and the history of the patient's disease, which often includes numerous episodes of unexplained abdominal pain, which was so severe that it forced the patient to report to emergency departments. A severe attack of porphyria is a medical emergency and requires hospitalization. Failure to diagnose or properly treat it may result in flaccid tetraplegia, respiratory failure, brain edema, coma, and sudden circulation detention.
References
Phillips JD. Hemebiosynthesis and the porphyrias. Mol Genet Metab. 2019 Nov;128(3):164-177. doi: 10.1016/j.ymgme.2019.04.008. Epub 2019 Apr 22. PMID: 31326287; PMCID: PMC7252266.
Cardenas JL, Guerrero C. Acute intermittent porphyria: general aspects with focus on pain. Curr Med Res Opin. 2018 Jul;34(7):1309-1315. doi: 10.1080/03007995.2018.1435521. Epub 2018 Feb 26. PMID: 29383964.
Suh Y, Gandhi J, Seyam O, Jiang W, Joshi G, Smith NL, Ali Khan S. Neurological and neuropsychiatric manifestations of porphyria. Int J Neurosci. 2019 Dec;129(12):1226-1233. doi: 10.1080/00207454.2019.1655014. Epub 2019 Sep 1. PMID: 31402774.
Swart G, Lim SS, Jude M. Acute intermittent porphyria presenting with posterior reversible encephalopathy syndrome (PRES) and abdominal pain. Pract Neurol. 2020 Dec;20(6):486-488. doi: 10.1136/practneurol-2020-002599. Epub 2020 Jun 17. PMID: 32554439.
https://www.orpha.net - The portal for rare diseases and orphan drugs. [Internet]
Bissell DM, Anderson KE, Bonkovsky HL. Porphyria. N Engl J Med. 2017 Aug 31;377(9):862-872. doi: 10.1056/NEJMra1608634. PMID: 28854095. (Bissell i in. 2017)
Anderson KE, Lobo R, Salazar D, Schloetter M, Spitzer G, White AL, Young RM, Bonkovsky HL, Frank EL, Mora J, Tortorelli S. Biochemical Diagnosis of Acute Hepatic Porphyria: Updated Expert Recommendations for Primary Care Physicians. Am J Med Sci. 2021 Aug;362(2):113-121. doi: 10.1016/j.amjms.2021.03.004. Epub 2021 Apr 16. PMID: 33865828.
Syed YY. Givosiran: A Review in Acute Hepatic Porphyria. Drugs. 2021 May;81(7):841-848. doi: 10.1007/s40265-021-01511-3. Epub 2021 Apr 19. PMID: 33871817.
Zhao L, Wang X, Zhang X, Liu X, Ma N, Zhang Y, Zhang S. Therapeutic strategies for acute intermittent porphyria. Intractable Rare Dis Res. 2020 Nov;9(4):205-216. doi: 10.5582/irdr.2020.03089. PMID: 33139979; PMCID: PMC7586882.
Szczeklik A, Gajewski P, et al. Interna Szczeklika. Medycyna Praktyczna. Kraków 2021, s. 1231-1234.
Ramanujam VS, Anderson KE. Porphyria Diagnostics-Part 1: A Brief Overview of the Porphyrias. CurrProtoc Hum Genet. 2015 Jul 1;86:17.20.1-17.20.26. doi: 10.1002/0471142905.hg1720s86. PMID: 26132003; PMCID: PMC4640448.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Aleksandra Czekaj, Kinga Ruszel, Robert Dubel, Julia Dubel, Natalia Namroży

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 1278
Number of citations: 0